Catharine Young: Cancer knows no borders, and neither should we
Catharine Young shared on LinkedIn:
“Cancer knows no borders, and neither should we. On Monday, July 15th, the Biden Cancer Moonshot, in coordination with the Department of State and the International Atomic Energy Agency, hosted the first White House Africa Cancer Care Forum that brought together 10 African nations to assess national priorities in cancer care as part of their comprehensive national strategy for improving health care systems and health outcomes.
In addition, the Biden Cancer Moonshot also announced over $100 million in new commitments from both the U.S. Government and private sector to reduce the burden of cancer in Africa.”
Further information.
Source: Catharine Young/LinkedIn
Catharine Young serves in the White House Office of Science and Technology Policy. Here she works to advance the Cancer Moonshot – The President and First Lady’s mission to decrease the cancer death rate by 50% over the next 25 years.
Her focus on cancer began with serving as the Senior Director of Science Policy at the Biden Cancer Initiative (BCI), a non-profit established in 2017 by then former Vice President Biden, leading efforts to bring together the biotech, technology, science, and academic fields to drive innovative solutions and breakthroughs against cancer.
Catharine then served as the Executive Director of a Rare Cancer Advocacy organization, where she advanced policy reform and awareness for all rare cancers.
Prior to BCI, Catharine served as the Senior Science and Innovation Policy Advisor and Head of the DC team for the Foreign Ministry of the UK. Awards include being selected as a TED Fellow, a New Voices Fellow of the National Academies of Science, Engineering and Medicine, a Presidential Leadership Scholar, and Social Enablers top 100 most inspiring social entrepreneurs.
Catharine is an advocate for women in STEM and has been a contributor to major social and media networks including TED-Ed, the Guardian and the UK Science and Innovation Network.